Chu NR - Search Results

1

Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP.

DeBenedette MA, Chu NR, Pollok KE, Hurtado J, Wade WF, Kwon BS, Watts TH. DeBenedette MA, et al. Among authors: chu nr. J Exp Med. 1995 Mar 1;181(3):985-92. doi: 10.1084/jem.181.3.985. J Exp Med. 1995. PMID: 7532686 Free PMC article.

2

Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells.

Chu NR, DeBenedette MA, Stiernholm BJ, Barber BH, Watts TH. Chu NR, et al. J Immunol. 1997 Apr 1;158(7):3081-9. J Immunol. 1997. PMID: 9120260

3

Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12.

Pizzoferrato E, Chu NR, Hawley TS, Lieu FH, Barber BH, Hawley RG, Watts TH, Berinstein NL. Pizzoferrato E, et al. Among authors: chu nr. Hum Gene Ther. 1997 Dec 10;8(18):2217-28. doi: 10.1089/hum.1997.8.18-2217. Hum Gene Ther. 1997. PMID: 9449375

4

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

Chu NR, Wu HB, Wu T, Boux LJ, Siegel MI, Mizzen LA. Chu NR, et al. Clin Exp Immunol. 2000 Aug;121(2):216-25. doi: 10.1046/j.1365-2249.2000.01293.x. Clin Exp Immunol. 2000. PMID: 10931134 Free PMC article.

5

T cells involved in human autoimmune disease are resistant to tolerance induction.

Dayan CM, Chu NR, Londei M, Rapoport B, Feldmann M. Dayan CM, et al. Among authors: chu nr. J Immunol. 1993 Aug 1;151(3):1606-13. J Immunol. 1993. PMID: 8335948

6

Identification of a T cell subset using a rabbit antibody raised against a T suppressor molecule.

North J, Weaver MS, Stammers AT, Chu NR, Chan A, Levy JG. North J, et al. Among authors: chu nr. J Immunol. 1988 Oct 1;141(7):2268-74. J Immunol. 1988. PMID: 2971723

7

Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF.

Cope AP, Aderka D, Wallach D, Kahan M, Chu NR, Brennan FM, Feldmann M. Cope AP, et al. Among authors: chu nr. Immunology. 1995 Jan;84(1):21-30. Immunology. 1995. PMID: 7890302 Free PMC article.

8

Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo.

Li Y, Chu N, Rostami A, Zhang GX. Li Y, et al. J Immunol. 2006 Aug 1;177(3):1679-88. doi: 10.4049/jimmunol.177.3.1679. J Immunol. 2006. PMID: 16849477

9

Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7.

Chu NR, Wu HB, Wu TC, Boux LJ, Mizzen LA, Siegel MI. Chu NR, et al. Cell Stress Chaperones. 2000 Nov;5(5):401-5. doi: 10.1379/1466-1268(2000)005<0401:ioahpt>2.0.co;2. Cell Stress Chaperones. 2000. PMID: 11189443 Free PMC article.

10

Disruption of IL-33 Signaling Limits Early CD8+ T Cell Effector Function Leading to Exhaustion in Murine Hemophagocytic Lymphohistiocytosis.

Rood JE, Burn TN, Neal V, Chu N, Behrens EM. Rood JE, et al. Front Immunol. 2018 Nov 20;9:2642. doi: 10.3389/fimmu.2018.02642. eCollection 2018. Front Immunol. 2018. PMID: 30515155 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters